Mark IV divests purolator automotive filter business
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 172 KB
- Volume
- 1999
- Category
- Article
- ISSN
- 1365-6937
No coin nor oath required. For personal study only.
✦ Synopsis
He believes top-line growth should continue at the levels seen in the first half of this year. While the second half of this fiscal year should reflect some benefit from the restructuring, Pall does not expect gross margins to improve significantly on the first half of this fiscal year. Krasnoff warned that earnings per share for the year (before one-time charges) are likely to be 10-15 per cent below last year.
Pall believes it can get back to strong earnings and sales growth next year given the full benefit of the US$50 million savings programme, better top-line growth in medical sales as countries implement aggressive blood filtration programmes, turnaround in microelectronics sales and improving margins in industrial systems.